AstraZeneca Pledges $15B More in Chinese Investments for Cell Therapies, Radiopharma - BioSpace

2026-01-29 - 13:40

AstraZeneca Pledges $15B More in Chinese Investments for Cell Therapies, Radiopharma BioSpace